{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:38:58Z","timestamp":1790753938115,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ebiom.2021.103805","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:49:25Z","timestamp":1641948565000},"page":"103805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and na\u00efve healthcare workers"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-9836","authenticated-orcid":false,"given":"Gemma","family":"Moncunill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-4060","authenticated-orcid":false,"given":"Roc\u00edo","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-4709","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-7257","authenticated-orcid":false,"given":"Robert A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Castellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-0595","authenticated-orcid":false,"given":"Pablo","family":"Hern\u00e1ndez-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Rod\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Llupi\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Puyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Rodrigo Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Carolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-9874","authenticated-orcid":false,"given":"Luis","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Trilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tortajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto L.","family":"Garc\u00eda-Basteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Doba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2021.103805_bib0001","unstructured":"WHO. COVID-19 vaccine tracker and landscape n.d. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines. 2021"},{"key":"10.1016\/j.ebiom.2021.103805_bib0002","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0003","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0004","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science (80-)"},{"key":"10.1016\/j.ebiom.2021.103805_bib0005","article-title":"Robust spike antibody responses and increased reactogenicity in seropositive individuals after a 1 single dose of SARS-CoV-2 mRNA vaccine 2 3","author":"Krammer","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.ebiom.2021.103805_bib0006","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","article-title":"Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149150","article-title":"First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19","volume":"131","author":"Mazzoni","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2021.103805_bib0008","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149154","article-title":"One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19","volume":"131","author":"Levi","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2021.103805_bib0009","first-page":"1","article-title":"Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose","volume":"1282","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103805_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc2103825","article-title":"SARS-CoV-2 antibody response in persons with past natural infection","volume":"385","author":"Anichini","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2021.103805_bib0012","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe2110605","article-title":"Vaccine effectiveness studies in the field","author":"Evans","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0013","first-page":"1","article-title":"SARS-CoV-2 vaccine effectiveness in a high-risk national population in a real-world setting","author":"Butt","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0014","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2021.103805_bib0015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","article-title":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2021.103805_bib0016","doi-asserted-by":"crossref","first-page":"n1960","DOI":"10.1136\/bmj.n1960","article-title":"Covid-19: how effective are vaccines against the delta variant?","volume":"374","author":"Baraniuk","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2021.103805_bib0017","article-title":"Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern","author":"Andrews","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.ebiom.2021.103805_bib0018","unstructured":"CDC. Interim public health recommendations for fully vaccinated people n.d. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/fully-vaccinated-guidance.html. 2021"},{"key":"10.1016\/j.ebiom.2021.103805_bib0019","unstructured":"WHO. COVID-19 advice for the public: getting vaccinated n.d. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines\/advice. 2021"},{"key":"10.1016\/j.ebiom.2021.103805_bib0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/d41586-021-01609-4","article-title":"After COVID, is one vaccine dose enough?","volume":"595","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103805_bib0021","article-title":"Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals","author":"Samanovic","year":"2021","journal-title":"MedRxiv Prepr Serv Heal Sci"},{"key":"10.1016\/j.ebiom.2021.103805_bib0022","unstructured":"WHO. WHO coronavirus (COVID-19) dashboard. 01\/09\/2021 n.d. 2021"},{"key":"10.1016\/j.ebiom.2021.103805_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101018","article-title":"Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals","volume":"38","author":"Demonbreun","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2021.103805_bib0024","unstructured":"Grupo de Trabajo T\u00e9cnico de Vacunaci\u00f3n Covid-19. Estrategia de vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Inf 27 Noviembre 2020:1\u2013107."},{"key":"10.1016\/j.ebiom.2021.103805_bib0025","unstructured":"de Catalunya G. Algoritme de vacunaci\u00f3 contra la COVID-19 2021:2021."},{"key":"10.1016\/j.ebiom.2021.103805_bib0026","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/d41586-021-02158-6","article-title":"COVID vaccine boosters: the most important questions","volume":"596","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103805_bib0027","first-page":"1","article-title":"SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines","author":"Shen","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2021.103805_bib0028","first-page":"1","article-title":"Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech\/Pfizer) vaccination in health care workers, Israel","volume":"5","author":"Lustig","year":"2021","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ebiom.2021.103805_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-24285-4","article-title":"COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants","volume":"12","author":"Jalkanen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103805_bib0030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.abg6105","article-title":"Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine\u2013elicited human sera","volume":"371","author":"Muik","year":"2021","journal-title":"Science (80-)"},{"key":"10.1016\/j.ebiom.2021.103805_bib0031","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103805_bib0032","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103805_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23473-6","article-title":"Immune response to SARS-CoV-2 variants of concern in vaccinated individuals","volume":"12","author":"Becker","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103805_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2021.07.019","article-title":"Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected","author":"Gidari","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2021.103805_bib0035","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103805_bib0036","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2107799","article-title":"Infection and vaccine-induced neutralizing-antibody responses to the SARS-CoV-2 B.1.617 variants","author":"Edara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0037","first-page":"20","article-title":"Correspondence reduced neutralisation of SARS-CoV-2 omicron","volume":"6736","author":"Chad","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2021.103805_bib0038","first-page":"1","article-title":"Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital","author":"Garcia-basteiro","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103805_bib0039","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1038\/s41467-021-24979-9","article-title":"Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses","volume":"12","author":"Ortega","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103805_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/infdis\/jiaa696","article-title":"SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish hospital after 3 months of follow-up","volume":"223","author":"Moncunill","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103805_bib0041","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ebiom.2021.103805_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ebiom.2021.103805_bib0043","article-title":"Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A and G against SARS-CoV-2 antigens","author":"Doba\u00f1o","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2021.103805_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.trsl.2021.02.006","article-title":"Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies","volume":"232","author":"Doba\u00f1o","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.ebiom.2021.103805_bib0046","series-title":"Modern Applied Statistics with S","author":"Venables","year":"2002"},{"key":"10.1016\/j.ebiom.2021.103805_bib0047","unstructured":"Kassambara A. Package \u2018 ggpubr \u2019 2019."},{"key":"10.1016\/j.ebiom.2021.103805_bib0048","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.ebiom.2021.103805_bib0049","first-page":"10","article-title":"Association of vaccine type and prior SARS-CoV-2 infection with symptoms and antibody measurements following vaccination among health care workers","author":"Debes","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0050","first-page":"30","article-title":"Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273","author":"Steensels","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2021.103805_bib0051","article-title":"Tolerability and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 (AZD1222)","volume":"19","author":"Flaxman","year":"2021","journal-title":"SSRN Electron J"},{"key":"10.1016\/j.ebiom.2021.103805_bib0052","first-page":"1","article-title":"Single dose administration, and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine","volume":"19","author":"Voysey","year":"2021","journal-title":"Ssrn"},{"key":"10.1016\/j.ebiom.2021.103805_bib0053","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19","volume":"384","author":"Doria-Rose","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0054","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science (80-)"},{"key":"10.1016\/j.ebiom.2021.103805_bib0055","doi-asserted-by":"crossref","unstructured":"Doba\u00f1o C, Ramirez A, Alonso S, et\u00a0al. Persistence and baseline determinants of seropositivity in health care workers up to nine months after COVID-19 2021:1\u20139.","DOI":"10.21203\/rs.3.rs-142984\/v1"},{"key":"10.1016\/j.ebiom.2021.103805_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100354","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.ebiom.2021.103805_bib0057","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-021-24622-7","article-title":"SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo","volume":"12","author":"Dorigatti","year":"2021","journal-title":"Nat Commun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:11:21Z","timestamp":1762456281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421005995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":57,"alternative-id":["S2352396421005995"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103805","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.08.21263232","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and na\u00efve healthcare workers","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103805"}}